Technical Analysis for CEMI - Chembio Diagnostics, Inc.

Grade Last Price % Change Price Change
grade B 7.05 0.00% 0.00
CEMI closed unchanged on Friday, January 18, 2019, on 14 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical CEMI trend table...

Date Alert Name Type % Chg
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 New Uptrend Bullish 0.00%
Jan 17 180 Bullish Setup Bullish Swing Setup 0.00%
Jan 17 Pocket Pivot Bullish Swing Setup 0.00%
Jan 17 Inside Day Range Contraction 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 16 Stochastic Sell Signal Bearish 3.22%
Jan 16 Wide Bands Range Expansion 3.22%

Older signals for CEMI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV antibodies, syphilis, and canine leishmaniasis. Its products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a multiplex Syphilis Screen and Confirm test, a multiplex test for the separate detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies and antigens. The company sells its products under its STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners. Chembio Diagnostics, Inc. sells its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology products. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.
Is CEMI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.55
52 Week Low 4.85
Average Volume 101,036
200-Day Moving Average 8.8871
50-Day Moving Average 6.2171
20-Day Moving Average 6.0725
10-Day Moving Average 6.759
Average True Range 0.3303
ADX 27.37
+DI 34.2447
-DI 13.5404
Chandelier Exit (Long, 3 ATRs ) 6.3091
Chandelier Exit (Short, 3 ATRs ) 5.8409
Upper Bollinger Band 7.5389
Lower Bollinger Band 4.6061
Percent B (%b) 0.83
BandWidth 48.296418
MACD Line 0.2236
MACD Signal Line 0.0686
MACD Histogram 0.155
Fundamentals Value
Market Cap 86.78 Million
Num Shares 12.3 Million
EPS -0.71
Price-to-Earnings (P/E) Ratio -9.93
Price-to-Sales 4.04
Price-to-Book 4.83
PEG Ratio -0.47
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.31
Resistance 3 (R3) 7.29 7.19 7.26
Resistance 2 (R2) 7.19 7.13 7.20 7.25
Resistance 1 (R1) 7.12 7.08 7.07 7.14 7.23
Pivot Point 7.02 7.02 7.00 7.03 7.02
Support 1 (S1) 6.95 6.96 6.90 6.97 6.87
Support 2 (S2) 6.85 6.91 6.86 6.85
Support 3 (S3) 6.78 6.85 6.84
Support 4 (S4) 6.80